astagraf xl tacrolimus extendedrelease capsules capsule coated extended release
1 INDICATIONS AND USAGE ASTAGRAF XL ® is indicated for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants in adult and pediatric patients who can swallow capsules intact [see Use in Specific Populations ( 8.4 ) and Clinical Studies ( 14.1 ), ( 14.2 )]. ASTAGRAF XL is a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants in adult and pediatric patients who can swallow capsules intact. ( 1 , 8.4 , 14.1 , 14.2 )
astellas pharma us, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING ASTAGRAF XL (tacrolimus) extended-release capsules are supplied in short, square bottles (see Table 19 ). Table 19: Strengths of ASTAGRAF XL 0.5 mg oblong capsule with a light yellow cap and orange body. capsule is branded with red “ 647” on capsule body and “0.5 mg” on the capsule cap. The bottle packaging is branded with a brown stripe. • 30-count in short, square bottles with a brown cap (NDC 0469-0647-73) 1 mg oblong capsule with a white cap and orange body. capsule is branded with red “ 677” on capsule body and “1 mg” on the capsule cap. The bottle packaging is branded with a blue stripe. • 30-count in short, square bottles with a blue cap (NDC 0469-0677-73) 5 mg oblong capsule with a grayish-red cap and orange body. capsule is branded with red “ 687” on capsule body and “5 mg” on the capsule cap. The bottle packaging is branded with an orange stripe. • 30-count in short, square bottles with an orange cap (NDC 0469-0687-73) Store and Dispense Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. astellas-logo-01 astellas-logo-02 astellas-logo-03
More pills like CAPSULE 1 mg 677